altretamine has been researched along with Osteosarcoma in 2 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hill, GJ | 1 |
Johnson, RO | 1 |
Metter, G | 1 |
Wilson, WL | 1 |
Davis, HL | 1 |
Grage, T | 1 |
Fletcher, WS | 1 |
Golomb, FM | 1 |
Cruz, AB | 1 |
Bielack, S | 1 |
Knop, J | 1 |
Delling, G | 1 |
Winkler, K | 1 |
1 trial available for altretamine and Osteosarcoma
Article | Year |
---|---|
[Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
Topics: Adolescent; Adult; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 1988 |
1 other study available for altretamine and Osteosarcoma
Article | Year |
---|---|
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo | 1976 |